File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Treatment of HBeAg-Positive Hepatitis B with Peginterferon and Lamivudine: Author's reply

TitleTreatment of HBeAg-Positive Hepatitis B with Peginterferon and Lamivudine: Author's reply
Authors
Issue Date2005
PublisherMassachusetts Medical Society. The Journal's web site is located at http://content.nejm.org/
Citation
New England Journal of Medicine, 2005, v. 353 n. 15, p. 1630-1631 How to Cite?
DescriptionLetters
Persistent Identifierhttp://hdl.handle.net/10722/43078
ISSN
2019 Impact Factor: 74.699
2015 SCImago Journal Rankings: 14.619
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorSong, Ken_HK
dc.contributor.authorRajvanshi, Pen_HK
dc.contributor.authorOrlent, Hen_HK
dc.contributor.authorLau, GKKen_HK
dc.date.accessioned2007-03-23T04:38:22Z-
dc.date.available2007-03-23T04:38:22Z-
dc.date.issued2005en_HK
dc.identifier.citationNew England Journal of Medicine, 2005, v. 353 n. 15, p. 1630-1631en_HK
dc.identifier.issn0028-4793en_HK
dc.identifier.urihttp://hdl.handle.net/10722/43078-
dc.descriptionLetters-
dc.format.extent60200 bytes-
dc.format.extent3155 bytes-
dc.format.mimetypeapplication/pdf-
dc.format.mimetypetext/plain-
dc.languageengen_HK
dc.publisherMassachusetts Medical Society. The Journal's web site is located at http://content.nejm.org/en_HK
dc.relation.ispartofNew England Journal of Medicine-
dc.rightsFrom New England Journal of Medicine, Kenneth Song, Pankaj Rajvanshi, Hans Orlent, George K.K. Lau, Treatment of HBeAg-Positive Hepatitis B with Peginterferon and Lamivudine, vol. 353, p. 1630-1631. Copyright © 2005 Massachusetts Medical Society. Reprinted with permission.en_HK
dc.subject.meshAntiviral agents - therapeutic useen_HK
dc.subject.meshHepatitis b virus - drug effects - geneticsen_HK
dc.subject.meshHepatitis b, chronic - drug therapyen_HK
dc.subject.meshInterferon alfa-2a - therapeutic useen_HK
dc.subject.meshPolyethylene glycols - therapeutic useen_HK
dc.titleTreatment of HBeAg-Positive Hepatitis B with Peginterferon and Lamivudine: Author's replyen_HK
dc.typeArticleen_HK
dc.description.naturepublished_or_final_versionen_HK
dc.identifier.doi10.1056/NEJMc052065-
dc.identifier.pmid16221792en_HK
dc.identifier.scopuseid_2-s2.0-26444483324-
dc.identifier.hkuros115851-
dc.identifier.volume353-
dc.identifier.issue15-
dc.identifier.spage1630-
dc.identifier.epage1631-
dc.identifier.isiWOS:000232486000033-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats